The Trump administration's "Manhattan project" for a COVID-19 vaccine has topped its biggest award given only two weeks ago to Novavax, Inc with its latest grant of $2.1 billion to pharmaceutical giant, GlaxoSmithKline, and partner Sanofi Pasteur to "speed up clinical development and manufacturing" of its recombinant vaccine candidate for the novel
大型制药巨头葛兰素史克公司,赛诺菲获得21亿美元研发COVID疫苗
Warp Speed行动正以创纪录的速度发放现金,这一次,世界上两个最大的疫苗公司都从中受益。